Location History:
- Sunnyvale, CA (US) (1991 - 1995)
- San Carlos, CA (US) (1994 - 1996)
- Cupertino, CA (US) (1995 - 1998)
Company Filing History:
10 out of 576 
2 out of 1,746 
2 out of 547 
Years Active: 1991-1998
Title: The Innovative Contributions of Randy W. Scott
Introduction
Randy W. Scott is a notable inventor based in Sunnyvale, CA, with a significant portfolio of 11 patents. His work primarily focuses on the development of polypeptides and protease inhibitors that have important applications in diagnostics and therapeutics.
Latest Patents
One of his latest patents involves basophil granule proteins, which are several natural polypeptides derived from the cytoplasmic granules of human basophils. These proteins, along with their modified forms, are described as useful for diagnostics and treatments related to inflammatory and IgE-mediated responses, parasitic infections, hypersensitivity reactions, and certain types of leukocytic leukemias. Another significant patent is for recombinant purified protease nexin, where DNA segments encoding two slightly different forms of protease nexin I are cloned and expressed. This innovation provides practical quantities of PN-I for diagnostic and therapeutic use, particularly in controlling conditions mediated by proteolytic activity.
Career Highlights
Randy has worked with prominent organizations such as Incyte Pharmaceuticals, Inc. and the Mayo Foundation for Medical Education and Research. His contributions in these roles have significantly advanced the field of medical research and therapeutic development.
Collaborations
Randy has collaborated with esteemed colleagues, including Joffre B. Baker and Michael P. McGrogan, further enhancing the impact of his work in the scientific community.
Conclusion
Randy W. Scott's innovative contributions to the fields of diagnostics and therapeutics through his patents exemplify the importance of research and development in medicine. His work continues to influence advancements in treating various health conditions.